Instytut Naukowo-Badawczy w Lublinie Sp. z o.o.
- Address
- ul. Polnocna 20, 20-064 Lublin, Poland
Psychiatry and Psychology at Instytut Naukowo-Badawczy w Lublinie Sp. z o.o.
Clinical research at this research site is centered on mental disorders, with studies focused on schizophrenia and Alzheimer’s disease. The trials are designed to explore new ways to address symptoms that affect thinking, behavior, and daily functioning.
- Research on schizophrenia is evaluating whether a new therapy can help reduce negative symptoms and support cognitive function.
- Studies in Alzheimer’s disease are examining treatment options for agitation and related behavioral concerns.
- Additional work is looking at whether treatment can improve cognitive impairment and overall functioning in people with mild to moderate Alzheimer’s disease.
Overall, the site is contributing to research that aims to improve symptom control, safety, and quality of life for people living with serious psychiatric and neurocognitive conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Instytut Naukowo-Badawczy w Lublinie Sp. z o.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Vafidemstat on Negative Symptoms and Cognitive Impairment in Adult Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial | Oryzon Genomics S.A. | Phase II | Recruiting | Sep 2021 | — |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Trospium Chloride | 1 | Unknown | 2026-06-01 | 2026-06-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.